Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 94
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 87
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,382 Results (Page 102 of 120)
- Relevance
  Sort by

Glucagon like peptide-1 agonists Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
89 Pages
Global

From

€3500EUR$4,298USD£3,157GBP

Peripheral Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2031

 Report
March 2025
150 Pages
Global

From

€3358EUR$3,850USD£2,927GBP

€4230EUR$4,850USD£3,687GBP

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

 Report
December 2023
117 Pages
Global

From

€13079EUR$14,995USD£11,399GBP

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2025

 Clinical Trials
May 2025
230 Pages
Global

From

€3009EUR$3,450USD£2,623GBP

Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
February 2024
245 Pages
Global

From

€6934EUR$7,950USD£6,043GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Brazil

From

€2191EUR$2,513USD£1,910GBP

€2922EUR$3,350USD£2,547GBP

France Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
77 Pages
France

From

€2191EUR$2,513USD£1,910GBP

€2922EUR$3,350USD£2,547GBP

Germany Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
75 Pages
Germany

From

€2191EUR$2,513USD£1,910GBP

€2922EUR$3,350USD£2,547GBP

Israel Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Israel

From

€2191EUR$2,513USD£1,910GBP

€2922EUR$3,350USD£2,547GBP

Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
82 Pages
Turkey

From

€2191EUR$2,513USD£1,910GBP

€2922EUR$3,350USD£2,547GBP

Androgen Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1308EUR$1,500USD£1,140GBP

Immunotherapy Drugs Market 2024-2028

 Report
November 2023
163 Pages
Global

From

€2181EUR$2,500USD£1,900GBP

Biological Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
90 Pages
Global

From

€3500EUR$4,298USD£3,157GBP

Throat Cancer Therapeutics Market 2024-2028

 Report
December 2023
158 Pages
Global

From

€2181EUR$2,500USD£1,900GBP

Gallbladder Cancer Therapeutics Market 2024-2028

 Report
December 2023
166 Pages
Global

From

€2181EUR$2,500USD£1,900GBP

Fabry Disease Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

 Report
June 2023
115 Pages
Global

From

€3925EUR$4,500USD£3,421GBP

Anticoagulants Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
November 2024
93 Pages
Global

From

€3500EUR$4,298USD£3,157GBP

Ulcerative Colitis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
115 Pages
Global

From

€4143EUR$4,750USD£3,611GBP

Regenerative Medicine Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
179 Pages
Global

From

€3500EUR$4,298USD£3,157GBP

Ischemic Heart Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
October 2024
77 Pages
Global

From

€3500EUR$4,298USD£3,157GBP

2,382 Results (Page 102 of 120)
- 1
- 100
- 101
- 102
- 103
- 104

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.